PAG
FATE icon

Private Advisor Group’s Fate Therapeutics FATE Stock Holding History

Private Advisor Group’s Portfolio FATE Stock Details FATE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-9,481
Closed -$367K – 2155
2022
Q1 		$367K Buy
9,481
+1,938
+26% +$75K ﹤0.01% 1567
2021
Q4 		$442K Sell
7,543
-4,757
-39% -$270K ﹤0.01% 1505
2021
Q3 		$730K Buy
12,300
+6,044
+97% +$474K ﹤0.01% 1343
2021
Q2 		$543K Buy
6,256
+38
+0.6% +$3.06K ﹤0.01% 1350
2021
Q1 		$512K Buy
6,218
+95
+2% +$9.1K ﹤0.01% 1290
2020
Q4 		$557K Buy
6,123
+1,123
+22% +$69.7K 0.01% 1169
2020
Q3 		$200K Hold
5,000
– – ﹤0.01% 1405
2020
Q2 		$172K Buy
+5,000
New +$149K ﹤0.01% 1433

Other funds holding FATE

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return